Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int Urogynecol J ; 31(5): 917-931, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-32125491

RESUMO

INTRODUCTION AND HYPOTHESIS: As noted in the 6th International Consultation on Incontinence (ICI) chapter "Initial Management of Urinary Incontinence in Women" recommendations call for including physiotherapy as a first-line therapy. METHODS: Building on this, checking available scientific evidence and using the International Classification of Functioning, Disabilities and Health, the following represents a holistic physiotherapist approach for initial evaluation of the health problem of urinary incontinence. RESULTS: This paper proposes a teaching module for every relevant health care professional dealing with the assessment of adult female urinary incontinence, focusing on optimal patient selection and appropriate treatment choice. CONCLUSION: The assessment stage involves the explicit decision as to whether "physiotherapy" is the treatment indicated for the patient, based on the findings of the physiotherapy assessment and supplemented by any medical information that accompanied the referral and evaluation.


Assuntos
Incontinência Urinária , Adulto , Feminino , Humanos , Modalidades de Fisioterapia , Encaminhamento e Consulta , Incontinência Urinária/terapia
2.
J Tissue Viability ; 18(3): 80-7, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19362001

RESUMO

PURPOSE: The maggots of Lucilia sericata are successfully used as a treatment for infected wounds. Many articles are published about possible direct antibacterial properties of maggots and their excretions/secretions (ES), but with different results. The present study reinvestigates the susceptibility of six bacterial strains to maggots and their ES. METHODS: Live maggots were added to a bacterial suspension. After incubation for 16 h, the bacterial growth in this suspension was compared with the growth in a suspension without maggots. We tested Instar-1 and Instar-3 maggots and compared nutrient broths. A turbidimetric assay investigated the antibacterial activity of ES. Finally, we compared the bacterial growth of Gram-positive and Gram-negative bacteria. RESULTS: The test with live maggots showed an increase of bacterial growth. Instar-1 maggots stimulated more bacterial growth than Instar-3 maggots, as well as the use of a more nutritious broth. The turbidimetric assay showed no inhibition of bacterial growth. For all bacteria, except Pseudomonas aeruginosa, an increase in bacterial growth was shown. CONCLUSION: There is no direct antibacterial effect of maggots and/or ES in vitro, however in clinical observations maggot therapy is successful. More research is needed to focus on possible indirect antibacterial activity, such as an immune-related effect.


Assuntos
Bactérias/crescimento & desenvolvimento , Dípteros/metabolismo , Desinfecção/métodos , Infecção dos Ferimentos/prevenção & controle , Ferimentos e Lesões/terapia , Animais , Secreções Corporais/química , Células Cultivadas , Humanos , Larva , Testes de Sensibilidade Microbiana
3.
Ned Tijdschr Geneeskd ; 152(14): 822-6, 2008 Apr 05.
Artigo em Holandês | MEDLINE | ID: mdl-18491826

RESUMO

A 30-year-old man presented with community-acquired pneumonia (CAP), directly following influenza. Sputum Gram stain confirmed Staphylococcus aureus pneumonia. Initial empirical antimicrobial therapy did not cover S. aureus. The isolated S. aureus strain contained genes encoding exotoxins, such as Panton-Valentine leukocidin (PVL). This exotoxin is associated with high mortality and methicillin resistance, but in this patient the strain was susceptible to methicillin. The patient died. In the Netherlands the risk of methicillin resistance in PVL-positive S. aureus CAP is low but real. This should be taken into account when selecting empirical treatment, which can include the combination of flucloxacillin and rifampicin. This case report illustrates the difficulty in predicting the causative agent in CAP and highlights the usefulness of the sputum Gram stain. Moreover, clinical awareness and recognition of S. aureus CAP remains essential to the early initiation of directed therapy.


Assuntos
Antibacterianos/uso terapêutico , Toxinas Bacterianas/biossíntese , Infecções Comunitárias Adquiridas/diagnóstico , Exotoxinas/biossíntese , Leucocidinas/biossíntese , Pneumonia Estafilocócica/diagnóstico , Pneumonia Estafilocócica/tratamento farmacológico , Staphylococcus aureus/isolamento & purificação , Adulto , Infecções Comunitárias Adquiridas/tratamento farmacológico , Infecções Comunitárias Adquiridas/etiologia , Evolução Fatal , Humanos , Influenza Humana/complicações , Masculino , Resistência a Meticilina , Testes de Sensibilidade Microbiana , Pneumonia Estafilocócica/etiologia , Escarro/microbiologia , Staphylococcus aureus/efeitos dos fármacos
4.
Zentralbl Chir ; 131 Suppl 1: S75-8, 2006 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-16575650

RESUMO

The ancient method of larval therapy for treatment of acute and chronic infections has become a revival and a new dimension with introduction of the Biobag (Vitapad). With use of this therapy trauma patients suffering infectious complications can be treated very effective, which can reduce the overall time needed for treatment and can result in diminished invalidity.


Assuntos
Traumatismos em Atletas/cirurgia , Desbridamento/métodos , Enterobacter cloacae , Infecções por Enterobacteriaceae/terapia , Larva , Osteomielite/terapia , Infecções Estafilocócicas/terapia , Infecção da Ferida Cirúrgica/terapia , Fraturas da Tíbia/cirurgia , Animais , Placas Ósseas , Remoção de Dispositivo , Floxacilina/uso terapêutico , Fixação Interna de Fraturas , Humanos , Masculino , Pessoa de Meia-Idade , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Cicatrização/fisiologia
5.
Ned Tijdschr Geneeskd ; 148(32): 1577-81, 2004 Aug 07.
Artigo em Holandês | MEDLINE | ID: mdl-15382556

RESUMO

Linezolid is the first of a new class of antibacterial agents, the oxazolidinones, to become available. Linezolid has a unique mechanism of action in its inhibition of bacterial protein synthesis in Gram-positive and a number of anaerobic bacteria. Because of this unique mechanism of action, linezolid exhibits no cross-resistance with other antibiotics and is effective against methicillin-resistant staphylococci, penicillin-resistant pneumococci and vancomycin-resistant enterococci. The excellent bioavailability after oral administration (almost 100%) makes it suitable for outpatient treatment and treatment by general practitioners. In the Netherlands, however, the indications for linezolid are limited by its high cost, the availability of other effective antibiotics for the treatment of sensitive micro-organisms, and the toxicity associated with a prolonged treatment period. Resistance to the new agent was reported rather quickly after the introduction of linezolid.


Assuntos
Acetamidas/uso terapêutico , Anti-Infecciosos/uso terapêutico , Bactérias Gram-Positivas/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Oxazolidinonas/uso terapêutico , Acetamidas/administração & dosagem , Acetamidas/economia , Acetamidas/farmacocinética , Administração Oral , Anti-Infecciosos/administração & dosagem , Anti-Infecciosos/economia , Anti-Infecciosos/farmacocinética , Bactérias Anaeróbias/efeitos dos fármacos , Disponibilidade Biológica , Farmacorresistência Bacteriana , Humanos , Linezolida , Testes de Sensibilidade Microbiana , Oxazolidinonas/administração & dosagem , Oxazolidinonas/economia , Oxazolidinonas/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA